Author Question: Which dimension is not commonly affected by suffering experienced by cancer patients? 1. Physical ... (Read 63 times)

mp14

  • Hero Member
  • *****
  • Posts: 534
Which dimension is not commonly affected by suffering experienced by cancer patients?
 
  1. Physical
  2. Geographical
  3. Psychological
  4. Social well-being

Question 2

A nurse is making a presentation to her administration on the need for a room that is comfortable, light, and calming that a patient can use during times of stress. What is the best argument for encouraging implementation at this facility?
 
  1. It has been proven effective.
  2. It is required for accreditation.
  3. It will be liked by the patients.
  4. It presents a more up-to-date care image.



asware1

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer: 2
Explanation: Fatigue and pain are dimensions of suffering. Commonalities exist in cancer patients from diverse cultures and locations. Psychological pain includes depression. Social well-being is affected by isolation and withdrawal.

Answer to Question 2

Answer: 1
Explanation: Evidence-based practice is the best argument for implementing new practices. Image and accreditation requirements are important but should be secondary considerations. Patient preferences should be considered but effective outcomes are most important.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library